European Medicines Company (EMA) the European Union’s drug regulator mentioned on Tuesday (January 11) that the technique of administering repeated booster doses at quick intervals was not viable as a long-term response to COVID-19 pandemic.
A fourth dose of Pfizer-BioNTech shot is already being administered to individuals over the age of 60 in Israel. Doses are additionally being given to immunocompromised sufferers and healthcare staff to guard them in opposition to Omicron surge.
However talking at a information convention the EMA’s Head of Vaccines Technique, Marco Cavaleri, mentioned a second booster could possibly be a contingency measure, notably in essentially the most weak, however that repeated, frequent vaccination was not viable within the long-term.
“We’ll find yourself doubtlessly having issues with immune response, and immune response might find yourself not being pretty much as good as we wish it to be,” he mentioned.
Additionally Learn | WHO says over 50% of Europeans on observe to contract Omicron variant of coronavirus
“Secondly, in fact, there may be the chance of fatiguing the inhabitants with the continual administration of boosters,” he advised a information convention.
Fourth dose of Covid vaccine is being given to “essentially the most weak residents” in Denmark as effectively.
Well being Minister Magnus Heunicke mentioned the transfer marked a “new chapter” within the combat in opposition to the unfold of the Covid-19 virus.
Well being authorities mentioned these involved could be contacted by early subsequent week.
Heunicke additionally introduced the re-opening of cultural establishments, closed since December 19 in a rustic the place 3,433 individuals have died for the reason that begin of the pandemic, in response to newest official information printed Wednesday.
(With inputs from businesses)